August 14, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus.
FDA Coronavirus (COVID-19) Update: August 13th, 2020
August 13, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Today, the FDA published an online Consumer Update with tips on how we can each take some simple steps to help slow the spread of the coronavirus disease and protect ourselves, our families and our communities.
Coronavirus
Tennessee Department of Education releases Toolkit on Child Wellbeing Checks
August 12, 2020
Nashville, TN – The Tennessee Department of Education has released a toolkit on child wellbeing checks to help ensure the needs of children are being met during and after extended periods away from school and to empower local communities to support child wellbeing.
Child Wellbeing Task Force Guidance to Ensure Children’s Needs Are Met; Tennessee Department of Education Provides Funding for Districts to Support This Work.
FDA Coronavirus (COVID-19) Update: August 11th, 2020
August 11, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the agency issued a warning letter to one firm for selling unapproved products with fraudulent COVID-19 Coronavirus claims.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 8th, 2020
August 8, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has taken the following actions in its ongoing response effort to the COVID-19 Coronavirus pandemic:
On August 6th, the FDA revoked the emergency use authorization (EUA) for Autobio Diagnostics Co., Ltd.’s, Anti-SARS-CoV-2 Rapid Test, a SARS-CoV-2 antibody test, due to performance concerns with the accuracy of the test.
Coronavirus.
FDA Coronavirus (COVID-19) Update: August 7th, 2020
August 7, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 6th, 2020
August 6, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued its first warning letter to New Life International and its second warning letter to Fishman Chemical of North Carolina, LLC, both of which distribute chloroquine phosphate products intended to treat disease in aquarium fish.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 5th, 2020
August 5, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
FDA has updated its COVID-19 Drug Shortages Response webpage to provide information regarding in-use time for certain drugs during the COVID-19 Coronavirus public health emergency.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 4th, 2020
August 4, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus
FDA Coronavirus (COVID-19) Update: August 1st, 2020
August 1, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly with the Federal Trade Commission to one company for selling fraudulent COVID-19 Coronavirus related products.
Coronavirus
